Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Axiron for Ejaculatory Dysfunction in Hypogonadism
NCT01419236Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Aug 2011
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of testosterone topical solution in Hypogonadism, sponsored by Eli Lilly and Company. Started Aug 2011; status: completed.
02
Drugs
testosterone topical solution
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on NCT01419236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01419236.